Hostname: page-component-77c89778f8-5wvtr Total loading time: 0 Render date: 2024-07-20T13:57:40.116Z Has data issue: false hasContentIssue false

Screening for Cognitive Disorders in Elderly Diabetics

Published online by Cambridge University Press:  23 March 2020

I. Baat
Affiliation:
Psychiatry “A” Department, Hedi Chaker University Hospital, Sfax, Tunisia
I. Abida
Affiliation:
Psychiatry “A” Department, Hedi Chaker University Hospital, Sfax, Tunisia
S. Omri
Affiliation:
Psychiatry “A” Department, Hedi Chaker University Hospital, Sfax, Tunisia
S. Ellouze
Affiliation:
Psychiatry “A” Department, Hedi Chaker University Hospital, Sfax, Tunisia
F. Hadj Kacem
Affiliation:
Endocrinology Department, Hedi Chaker University Hospital, Sfax, Tunisia
L. Affes
Affiliation:
Endocrinology Department, Hedi Chaker University Hospital, Sfax, Tunisia
M. Abid
Affiliation:
Endocrinology Department, Hedi Chaker University Hospital, Sfax, Tunisia
J. Masmoudi
Affiliation:
Psychiatry “A” Department, Hedi Chaker University Hospital, Sfax, Tunisia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Old people with diabetes are more likely to develop cognitive impairment, Alzheimer's disease and vascular dementia. However, the determinants of the association between diabetes and cognitive impairments are only partially known.

Objectives

To evaluate cognitive disorders in elderly diabetic patients and to identify risk factors of cognitive impairment in this population.

Methods

It was a cross-sectional study. It involved outpatients aged 65 and older, who were followed for diabetes in the endocrinology department at the Hedi Chaker University Hospital in Sfax (Tunisia), from October 1 to December 31, 2015. For each patient, we collected sociodemographic, clinical and therapeutic data. We used the Montreal Cognitive Assessment (MoCA) to identify mild cognitive decline (score < 26/30).

Results

We identified 70 patients, all with type 2 diabetes. The average age was 66.8 years. The sex ratio (M: F) was 0.7. The mean duration of diabetes was 14.76 years. The average MoCA score was 20.68 ± 6. Forty patients (57%) had cognitive decline. The cognitive impairment was statistically correlated with female sex (P = 0.02), low level of education (P = 0.00), high levels of glycated hemoglobin (Hb A1c ≥ 7%) (P = 0.00), presence of hypoglycemic episodes (P = 0.05) and presence of dyslipidemia (P = 0.00).

Conclusion

Our study confirmed the high rate of cognitive decline in older type 2 diabetes patients. The profile of subjects at risk was consistent with the literature: poorly controlled diabetes, severe recurrent hypoglycaemia and associated dyslipidemia. Acting on these risk factors would prevent cognitive decline and therefore progression to dementia.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster Viewing: Others
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.